Phibro Animal Health Corp (PAHC)
23.72
-0.04
(-0.15%)
USD |
NASDAQ |
Nov 22, 16:00
23.72
0.00 (0.00%)
After-Hours: 16:05
Phibro Animal Health Enterprise Value: 1.347B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.347B |
| November 20, 2024 | 1.332B |
| November 19, 2024 | 1.346B |
| November 18, 2024 | 1.361B |
| November 15, 2024 | 1.375B |
| November 14, 2024 | 1.393B |
| November 13, 2024 | 1.408B |
| November 12, 2024 | 1.399B |
| November 11, 2024 | 1.419B |
| November 08, 2024 | 1.350B |
| November 07, 2024 | 1.336B |
| November 06, 2024 | 1.320B |
| November 05, 2024 | 1.310B |
| November 04, 2024 | 1.290B |
| November 01, 2024 | 1.323B |
| October 31, 2024 | 1.321B |
| October 30, 2024 | 1.344B |
| October 29, 2024 | 1.336B |
| October 28, 2024 | 1.340B |
| October 25, 2024 | 1.333B |
| October 24, 2024 | 1.333B |
| October 23, 2024 | 1.349B |
| October 22, 2024 | 1.364B |
| October 21, 2024 | 1.342B |
| October 18, 2024 | 1.359B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.371B |
| October 16, 2024 | 1.390B |
| October 15, 2024 | 1.362B |
| October 14, 2024 | 1.368B |
| October 11, 2024 | 1.336B |
| October 10, 2024 | 1.311B |
| October 09, 2024 | 1.283B |
| October 08, 2024 | 1.276B |
| October 07, 2024 | 1.230B |
| October 04, 2024 | 1.247B |
| October 03, 2024 | 1.240B |
| October 02, 2024 | 1.266B |
| October 01, 2024 | 1.279B |
| September 30, 2024 | 1.296B |
| September 27, 2024 | 1.267B |
| September 26, 2024 | 1.269B |
| September 25, 2024 | 1.267B |
| September 24, 2024 | 1.266B |
| September 23, 2024 | 1.264B |
| September 20, 2024 | 1.276B |
| September 19, 2024 | 1.281B |
| September 18, 2024 | 1.271B |
| September 17, 2024 | 1.279B |
| September 16, 2024 | 1.246B |
| September 13, 2024 | 1.264B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
780.14M
Minimum
Nov 30 2023
1.514B
Maximum
Jul 01 2021
1.110B
Average
1.101B
Median
Sep 03 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Haemonetics Corp | 5.216B |
| Baxter International Inc | 28.43B |
| Globus Medical Inc | 11.30B |
| Insulet Corp | 18.87B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.975M |
| Revenue (Quarterly) | 260.43M |
| Total Expenses (Quarterly) | 242.73M |
| EPS Diluted (Quarterly) | 0.17 |
| Gross Profit Margin (Quarterly) | 32.06% |
| Profit Margin (Quarterly) | 2.68% |
| Earnings Yield | 1.81% |
| Operating Earnings Yield | 7.46% |
| Normalized Earnings Yield | 3.221 |